Skip to main content

Hydroxyurea Use Among Children with Sickle Cell Anemia

CBE ID
3595
1.4 Project
Primary Care and Chronic Illness
Endorsed
Endorsement Status
Endorsed
1.1 New or Maintenance
Maintenance
E&M Cycle
Fall 2020
Is Under Review
No
Next Planned Maintenance Review
Primary Care and Chronic Illness Fall 2024
1.3 Measure Description

The percentage of children ages 1 to 18 years with sickle cell anemia (SCA) who were dispensed hydroxyurea for at least 300 days within the measurement year.

    • 1.14 Numerator

      The number of children ages 1 to 18 years with sickle cell anemia (SCA) who were dispensed hydroxyurea for at least 300 days within the measurement year.

    • 1.15 Denominator

      The number of children ages 1 to 18 years with sickle cell anemia (SCA) within the measurement year.

    • Exclusions

      NA

    • Most Recent Endorsement Activity
      Endorsed Primary Care and Chronic Illness Fall Cycle 2020
      Initial Endorsement
      Last Updated